切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 124 -128. doi: 10.3877/cma.j.issn.1674-1358.2021.02.009

所属专题: 经典病例 文献

短篇论著

48例腺病毒55型所致急性呼吸系统感染者的临床特点
王心静1, 王仲元1, 刘晓1, 徐静1, 曹彦1, 陈志1, 丹子军1, 梁建琴1,()   
  1. 1. 100091 北京,解放军总医院第八医学中心结核病学部
  • 收稿日期:2020-04-25 出版日期:2021-04-15
  • 通信作者: 梁建琴
  • 基金资助:
    传染病防治科技重大专项"结核病新疫苗的临床试验和关键技术研究"(No. 2018ZX10731301); 国家自然科学基金(No. 81701974)

Clinical characteristics of 48 patients of respiratory system infection caused by human adenovirus type 55

Xinjing Wang1, Zhongyuan Wang1, Xiao Liu1, Jing Xu1, Yan Cao1, Zhi Chen1, Zijun Dan1, Jianqin Liang1,()   

  1. 1. Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing 100091, China
  • Received:2020-04-25 Published:2021-04-15
  • Corresponding author: Jianqin Liang
引用本文:

王心静, 王仲元, 刘晓, 徐静, 曹彦, 陈志, 丹子军, 梁建琴. 48例腺病毒55型所致急性呼吸系统感染者的临床特点[J]. 中华实验和临床感染病杂志(电子版), 2021, 15(02): 124-128.

Xinjing Wang, Zhongyuan Wang, Xiao Liu, Jing Xu, Yan Cao, Zhi Chen, Zijun Dan, Jianqin Liang. Clinical characteristics of 48 patients of respiratory system infection caused by human adenovirus type 55[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(02): 124-128.

目的

分析北京某次暴发性腺病毒-55型(HAdV-55)所致呼吸系统感染的临床特点,以提高对腺病毒-55型呼吸系统感染的认识和诊疗水平。

方法

诊断为急性HAdV-55呼吸道感染的48例患者于2020年1月26日至2020年2月6日由解放军总医院第八医学中心集中收治,回顾性收集和分析患者的临床资料,包括症状、体征、实验室指标[包括血常规、红细胞沉降率、C-反应蛋白(CRP)、血生化、病原体核酸检测]、治疗方法及预后等。根据CT影响是否出现变化性肺部病变将入组患者分为肺炎组(18例)和上呼吸道感染组(30例)。两组患者治疗前后呈正态分布的计量资料比较采用配对t检验,症状分布比例比较采用卡方检验或Fisher确切概率法检验。

结果

入组48例患者平均年龄为(20.6 ± 1.8)岁,83.3%(40/48)病例是从中等以下城市或农村初次入京;58.3%(28/48)患者最高体温> 39 ℃,其中肺炎组12例,上呼吸道感染组16例(χ2 = 0.823、P = 0.346);84.6%(22/26)咯痰患者咯黄痰,其中肺炎组11例,上呼吸道感染组11例(χ2 = 0.142、P = 0.706),差异均无统计学意义。去除6例治疗超过4 d的患者,初诊42例患者外周血白细胞平均计数为(9.03 ± 0.37)× 109/L,而肺炎组[(9.08 ± 3.01)× 109/L]和上呼吸道感染组[(9.01 ± 2.02)× 109/L]差异无统计学意义(t = -0.086、P = 0.932),38.1%(16/42)患者白细胞计数> 10 × 109/L;42例初诊患者CRP平均为(29.0 ± 17.2)mg/L,而肺炎组[(30.2 ± 13.7)mg/L]和上呼吸道感染组[(28.3 ± 19.0)mg/L]差异无统计学意义(t =-0.338、P = 0.737);肺炎病灶基本位于肺外带,接近胸膜或与胸膜连接;体温恢复正常后第7天,复测的8例患者中7例HAdV核酸阳性。

结论

人HAdV-55所致急性呼吸系统感染者的症状及血常规表现出高热、黄痰、白细胞和中性粒细胞增高及淋巴细胞计数正常等细菌性呼吸系统感染的特点;患者体温恢复正常后1周内仍可能具有传染性。

Objective

To investigate the clinical characteristics of a fulminant respiratory infection caused by human adenovirus type 55 (HAdV-55) in Beijing, and to raise the awareness and level of diagnosis and treatment of HAdV-55 respiratory infection.

Methods

Total of 48 patients diagnosed as acute HAdV-55 respiratory tract infection were treated in The 8th Medical Center of PLA General Hospital. The clinical information of patients were collected and analyzed, retrospectively, including symptoms, signs, results of laboratory examination [including blood routine, erythrocyte sedimentation rate, C-reactive protein (CRP), blood biochemistry, pathogen nucleic acid detection, etc.], treatment methods and prognosis. Patients were divided into pneumonia group (18 cases) and upper respiratory tract infection group (30 cases) according to with or without variative lung lesions on CT image. Data with normal distribution of before and after treatment of the two groups were compared with paired t test, and the proportion of symptom distribution were analyzed by chi-square test or Fisher exact probability test.

Results

The average age of 48 patients was (20.6 ± 1.8) years old, and 83.3% (40/48) cases were initial entry to Beijing from urban or rural areas below secondary level. There were 58.3% (28/48) patients with the highest body temperature > 39℃, including 12 cases in pneumonia group and 16 cases in upper respiratory tract infection group (χ2 = 0.823, P = 0.346); 84.6% (22/26) patients with sputum had yellow sputum, including 11 cases in pneumonia group and 11 cases in upper respiratory tract infection group (χ2 = 0.142, P = 0.706), both without significant differences. Excepte for 6 patients treated for longer than 4 d, the average number of peripheral white blood cells in 42 patients was (9.03 ± 0.37) × 109/L, there was no significant difference between pneumonia group [(9.08 ± 3.01) × 109/L] and upper respiratory tract infection group [(9.01 ± 2.02) × 109/L](t =-0.086, P = 0.932). Leukocyte count in 38.1% (16/42) patients were > 10 × 109/L. The average CRP of 42 patients at first visit was (29.0 ± 17.2) mg/L, but there was no significant difference between pneumonia group [(30.2 ± 13.7) mg/L] and upper respiratory tract infection group [(28.3 ± 19.0)mg/L](t =-0.338, P = 0.737). The focus of pneumonia was basically located in the extrapulmonary zone, close to or connected to the pleura. Seven days after the patient’s temperature returned to normal, 7 cases were positive for HAdV nuclear acid among the 8 cases re-measured.

Conclusions

With high fever, yellow sputum, increased white blood cell and neutrophil count, and normal lymphocyte count, acute respiratory infection caused by HAdV-55 showed the characteristics of bacterial infection. The virus nucleic acid remains contagious within one week after the recovery of body temperature.

表1 48例人HAdV-55呼吸系统感染者的症状[例(%)]
表2 42例初诊HAdV-55呼吸道感染者的血常规指标( ± s
[1]
Scott MK, Chommanard C, Lu X, et al. Human adenovirus associated with severe respiratory infection, Oregon, USA,2013-2014[J]. Emerg Infect Dis,2016,22(6):1044-1051.
[2]
Wo Y, Lu QB, Huang DD, et al. Epidemical features of HAdV-3 and HAdV-7 in pediatric pneumonia in Chongqing, China[J]. Arch Virol,2015,160(3):633-638.
[3]
毛乃颖, 朱贞, 雷振强, 等. 新型人腺病毒55型在中国10年的持续流行及其基因进化分析[J]. 中华实验和临床病毒学杂志,2018,32(2):124-129.
[4]
Lee J, Choi EH, Lee HJ. Clinical severity of respiratory adenovira!infection by serotypes in Korean children over 17 consecutive years(1991-2007)[J]. J Clin Virol,2010,49(2):115-120.
[5]
Noda M, Yoshida T, Sakaguch T, et al. Molecular and epidemiological analyses of human adenovirus type 7 strains isolated from the 1995 nationwide outbreak in Japan[J]. J Clin Microbiol,2002,40(1):140-145.
[6]
许晶, 岳姝婷, 马萍, 等. 西安市流感样病例中人腺病毒感染特点分析[J]. 中华实验和临床病毒学杂志,2017,31(3):218-222.
[7]
刘腾颖子, 吕星, 黄达娜, 等. 201-2012年深圳市呼吸道腺病毒分子分型及其流行特征[J]. 热带医学杂志,2014,14(1):12-15.
[8]
马广源, 刘瑞霞, 肖勇, 等. 2011-2013年无锡地区人腺病毒流行特征与分型[J]. 中华实验和临床病毒学杂志,2016,30(5):457-460.
[9]
邓洁, 钱渊, 赵林清, 等. 2003-2012年北京儿童急性呼吸系统感染中腺病毒监测及流行型别分析[J]. 病毒学报,2013,6(29):615-619.
[10]
Seto D, Jones MS, Dyer DW, et al. Characterizing,typing, and haming human adenovirus type 55 in the era of whole genome data[J]. J Clin Virol,2013,58(4):741-742.
[11]
Sun B, He HY, Wang Z, et al. Emergent severe acute respiratory distress syndrome caused by adenuvirus type 55 in immunocompetent adults in 2013: a prospective observational study[J]. Crit Care,2014,18(4):456.
[12]
Chen M, Zhu Z, Huang F, et al. Adenoviruses associated with acute respiratory diseases Reported in Beijing from 2011 to 2013[J]. PLoS One,2015,10(3):e0121375.
[13]
全军传染病专业委员会. 腺病毒感染诊疗指南[J]. 解放军医学杂志,2013,38(7):529-534.
[14]
Tan DY, Zhu HD, Fu YY, et al. Severe Community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series[J]. PLoS One,2016,11(3):e0151199.
[15]
Liesbeth L, Erik DC, Lieve N. Clinical features and treatment of adenovirus infections[J]. Rev Med Virol,2008,18(6):357-374.
[16]
Sluijs K, Poll T, Lutter R, Bench-to-bedside review: Bacterial pneumonia with influenza--pathogenesis and clinical implications[J]. Crit Care,2010,14(2):219-226.
[17]
Kumar A, Zarychanski R, Pinto R, et al. Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada[J]. JAMA,2009,302(17):1872-1879.
[18]
Tao RJ, Luo XL, Xu W, et al. Viral infection in community acquired pneumonia patients with fever: a prospective observational study[J]. J Thorac Dis,2018,10(7):4387-4395.
[19]
Zhou F, Wang YM, Liu YM, et al. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network[J]. Eur Respir J,2019,54(2):1802406.
[20]
Madhi SA, Klugman KP, Vaccine Trialist G. A role for Streptococcus pneumoniae in virus-associated pneumonia[J]. Nat Med,2004,10(8):811-813.
[21]
Boyd M, Clezy K, Lindley R, et al. Pandemic influenza: clinical issues[J]. Med J Aust,2006,185(S10):S44-S47.
[22]
Schuetz P, Chiappa V, Bilel M, et a1. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms[J]. Arch Intern Med,2011,171(15):1322-1331.
[23]
Friis B, Andersen P, Brenoe E, et al. Antibiotic treatment of pneumonia and bronchiolitis[J]. Arch Dis Child,1984,59(11):1038-1045.
[24]
人腺病毒呼吸道感染预防控制技术指南编写审定专家组. 人腺病毒呼吸道感染预防控制技术指南(2019年版)[J]. 中华预防医学杂志,2019,53(11):1088-1093.
[25]
Pan Y, Guan H. Imaging changes in patients with 2019-nCov[J]. Eur Radiol,2020,30(7):3612-3613.
[1] 葛飞霞, 蒋银, 杨丹. 酶联免疫吸附测定法与PCR仪检测在乙型肝炎诊断中的临床应用[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 310-315.
[2] 何小军, 丁雨红. 慢性阻塞性肺疾病合并下呼吸道感染病原菌分布及炎症指标变化[J]. 中华危重症医学杂志(电子版), 2022, 15(02): 127-130.
[3] 罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.
[4] 方辉, 郑武田, 范晓鋆, 刘梦莹. 连花清瘟颗粒联合帕拉米韦对儿童病毒性急性上呼吸道感染的疗效及免疫功能影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 350-356.
[5] 唐梅, 杨凡, 王旖旎, 向韵, 伍晋辉, 罗红. 儿童保健门诊蛋白质-能量营养不良患儿病因分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 69-76.
[6] 夏金蓉, 王慧, 刘玉珊, 谢江. COVID-19疫情暴发前、后呼吸道感染住院患儿呼吸道病原体的变化[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 712-721.
[7] 廖雄宇, 邱坤银, 黄科, 黎阳, 徐宏贵, 方建培, 周敦华. 支气管肺泡灌洗液宏基因组二代测序对儿童肺部感染的病原体诊断价值[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 562-568.
[8] 蒙姣姣, 胡刚, 欧阳涣堃. 肺癌术前淋巴结转移及MWA手术效果预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 547-549.
[9] 郭长江, 冷建刚, 邵伟. 阿莫西林克拉维酸钾联合布地奈德治疗小儿反复细菌性呼吸道感染[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 394-396.
[10] 宋昕, 耿涛, 刘长春. 老年下呼吸道感染者血清25-羟维生素D3水平与血清炎症因子水平的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 215-217.
[11] 徐冰, 程明斌, 赵国华. CT影像学征象对局灶性肺炎型肺癌与肺部炎性病变的鉴别意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 58-60.
[12] 汪超, 翟丽丽, 王洋. 以反复呼吸系统感染为主要表现的Good综合征一例[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 920-922.
[13] 乔艳艳, 韩璐瑶, 王在强, 冯艳珍, 李婵, 李玉娟, 金发光, 傅恩清. 环介导恒温扩增芯片法在下呼吸道感染病原体检测中的临床应用[J]. 中华肺部疾病杂志(电子版), 2022, 15(04): 477-480.
[14] 张志华, 肖晓晨, 梅少奇. 维生素D3辅助治疗哮喘合并呼吸道感染对气道重塑及免疫功能影响[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 355-357.
[15] 时庆康, 张瑞, 吴强, 尹成敏. 反复上呼吸道感染患儿血清微量元素缺乏临床分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 352-354.
阅读次数
全文


摘要